S. Bodard

发表

Maternal Rat Metabolomics: Amniotic Fluid and Placental Metabolic Profiling Workflows.

L. Nadal-Desbarats, P. Emond, L. Galineau, 2021, Journal of proteome research.

New implanted Doppler sensors for the assessment of the main fetal hemodynamics.

D. Maulik, M. Berson, A. Locatelli, 1992, Ultrasound in medicine & biology.

Concurrent changes in intracranial pressure, cerebral blood flow velocity, and brain energy metabolism in rabbits with acute intracranial hypertension

M. Berson, J. Bray, S. Bodard, 1994, Child's Nervous System.

Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system

C. Belzung, I. Yalcin, S. Chalon, 2007, Behavioural pharmacology.

The specific PKR inhibitor C16 prevents apoptosis and IL-1β production in an acute excitotoxic rat model with a neuroinflammatory component

G. Page, C. Tronel, S. Chalon, 2014, Neurochemistry International.

First Metabolomic Signature of Blood-Brain Barrier Opening Induced by Microbubble-Assisted Ultrasound

J. Escoffre, A. Bouakaz, L. Nadal-Desbarats, 2022, Frontiers in Molecular Neuroscience.

Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism

D. Guilloteau, C. Belzung, P. Vourc'h, 2010, Neuroscience Letters.

Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1

C. Tronel, S. Chalon, S. Bodard, 2018, Neural regeneration research.

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation

D. Guilloteau, N. Arlicot, A. Katsifis, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport

M. Sitbon, E. Lagrue, S. Chalon, 2010, Journal of Biomedical Science.

Lamotrigine Is Neuroprotective in the Energy Deficiency Model of MPTP Intoxicated Mice

P. Gressens, E. Lagrue, S. Chalon, 2007, Pediatric Research.

MPTP intoxication in mice: a useful model of Leigh syndrome to study mitochondrial diseases in childhood

F. Medja, A. Lombès, E. Lagrue, 2009, Metabolic Brain Disease.

Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study

E. Lagrue, S. Chalon, P. Castelnau, 2009, Metabolic Brain Disease.

Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease

C. Tronel, S. Chalon, S. Routier, 2020, Neural regeneration research.

Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter.

J. Vercouillie, D. Guilloteau, A. Chartier, 2022, European journal of medicinal chemistry.

A new iodinated tropane derivative (β‐CDIT) for in vivo dopamine transporter exploration: Comparison with β‐CIT

D. Guilloteau, J. Baulieu, P. Emond, 1997, Synapse.

Oxidative Stress Is Related to the Deleterious Effects of Heme Oxygenase-1 in an In Vivo Neuroinflammatory Rat Model

C. Tronel, N. Arlicot, S. Chalon, 2013, Oxidative medicine and cellular longevity.

ADAM is an effective tool for in vivo study of serotonergic function: Validation in rat models

J. Vercouillie, D. Guilloteau, P. Emond, 2004, Synapse.

Pharmacological Characterization of ( E )- N -(4-Fluorobut-2-enyl)-2 (cid:1) -carbomethoxy-3 (cid:1) -(4 (cid:1) -tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter

C. Halldin, D. Guilloteau, J. Madelmont, 2006 .

Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers

J. Vercouillie, C. Tauber, Anne-Claire Dupont, 2021, Translational Psychiatry.

N-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice

C. Belzung, S. Vancassel, S. Chalon, 2020 .

Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [18F] PET tracer

J. Vercouillie, D. Guilloteau, N. Arlicot, 2018, Journal of enzyme inhibition and medicinal chemistry.

Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation

D. Guilloteau, N. Arlicot, A. Katsifis, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain

D. Guilloteau, S. Chalon, C. Pellevoisin, 1996, Synapse.

An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration.

D. Guilloteau, L. Pourcelot, J. Ombetta, 1996, Life sciences.

Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer's Disease versus Age-Matched Controls: A Presymptomatic Stage Study

S. Krantic, G. Page, C. Klein, 2016, International journal of Alzheimer's disease.

Ex vivo and in vivo evaluation of (2R,3R)‐5‐[18F]‐fluoroethoxy‐ and fluoropropoxy‐benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter

M. Fulham, S. Eberl, R. Fulton, 2007, Synapse.

(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.

Y. Zea‐Ponce, M. Kassiou, D. Guilloteau, 2007, Nuclear medicine and biology.

Vascular resistance quantification in high flow resistance areas using the Doppler method.

M. Berson, A. Locatelli, P. Arbeille, 1995, Ultrasound in medicine & biology.

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease

D. Guilloteau, P. Vourc'h, L. Sensébé, 2008, Neurochemistry International.

Inflammatory process in Parkinson disease: neuroprotection by neuropeptide Y

A. Gaillard, S. Chalon, S. Pain, 2019, Fundamental & clinical pharmacology.

Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice

C. Belzung, I. Yalcin, S. Chalon, 2008, Psychopharmacology.

[ 18 F]‐labeled positron emission tomography ligand for the histamine H4 receptor

J. Vercouillie, S. Chalon, S. Routier, 2021, Journal of Labelled Compounds and Radiopharmaceuticals.

Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.

D. Guilloteau, C. Belzung, S. Chalon, 2005, Brain research. Developmental brain research.

Maternal Exposure to LPS Induces Hypomyelination in the Internal Capsule and Programmed Cell Death in the Deep Gray Matter in Newborn Rats

P. Gressens, S. Chalon, E. Saliba, 2006, Pediatric Research.

n-3 Polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice Published, JLR Papers in Press, November 8, 2007.

C. Belzung, S. Vancassel, S. Chalon, 2008, Journal of Lipid Research.

Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [18F]LBT-999 in a Parkinson’s Disease Rat Model

J. Vercouillie, D. Guilloteau, G. Page, 2015, Front. Med..

Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.

C. Prunier-Aesch, S. Chalon, S. Pain, 2013, Experimental and Toxicological Pathology.

Development of Nanosized, Pramipexole-Encapsulated Liposomes and Niosomes for the Treatment of Parkinson’s Disease

D. Guilloteau, S. Chalon, A. Ozer, 2017 .

Delivery of anti-cancer drugs using microbubble-assisted ultrasound in digestive oncology: from preclinical to clinical studies

J. Escoffre, A. Bouakaz, S. Bodard, 2022, Expert opinion on drug delivery.

Partial protective effects of melatonin on developing brain in a rat model of chorioamnionitis

P. Gressens, Elie Saliba, S. Chalon, 2021, Scientific Reports.

Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia

D. Guilloteau, S. Chalon, J. Laugier, 2003, Neuroscience Letters.

Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat

D. Guilloteau, S. Vancassel, S. Chalon, 2004, Journal of neurochemistry.

Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids.

D. Guilloteau, L. Zimmer, G. Durand, 2000, Journal of lipid research.

Assessment of the fetal PO2 changes by cerebral and umbilical Doppler on lamb fetuses during acute hypoxia.

D. Maulik, M. Berson, A. Locatelli, 1995, Ultrasound in medicine & biology.

Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

Denis Guilloteau, Sylvie Chalon, D. Guilloteau, 2000, Neuroscience Letters.

Synthesis and ex vivo evaluation of aza-trozamicol analogs as SPECT radiotracers for exploration of the vesicular acetylcholine transporter

D. Guilloteau, P. Emond, S. Chalon, 2007 .

Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6‐hydroxydopamine rat model of Parkinson's disease

E. Vierron, D. Guilloteau, N. Arlicot, 2012, Synapse.

Extensive exploration of a novel rat model of Parkinson's disease using partial 6‐hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches

J. Vercouillie, C. Tronel, F. Dollé, 2018, Synapse.

Synthesis and characterization of [125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitor.

J. Ombetta, S. Chalon, J. Besnard, 1995, Nuclear medicine and biology.

Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter

C. Halldin, D. Guilloteau, H. Hall, 2006, Journal of Pharmacology and Experimental Therapeutics.

Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease

D. Guilloteau, P. Emond, S. Chalon, 1999, Synapse.

mRNA D2 Dopaminergic Receptor Expression after Hypoxia-Ischemia in Rat Immature Brain

P. Gressens, D. Guilloteau, S. Chalon, 2001, Neonatology.

Respiratory chain inhibition: one more feature to propose MPTP intoxication as a Leigh syndrome model

C. Rocher, T. Letellier, P. Castelnau, 2016, Journal of Bioenergetics and Biomembranes.

Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum.

A. Reynolds, M. Kassiou, D. Guilloteau, 2012, ACS chemical neuroscience.

Evaluation of cerebral blood flow in rabbits with transcranial Doppler sonography: first results.

L Pourcelot, M Berson, A Roncin, 1991, Ultrasound in medicine & biology.

SHR/NCrl rats as a model of ADHD can be discriminated from controls based on their brain, blood, or urine metabolomes

L. Nadal-Desbarats, H. Blasco, D. Dufour‐Rainfray, 2021, Translational Psychiatry.

Translocator Protein (18 kDa) Mapping with [125I]-CLINDE in the Quinolinic Acid Rat Model of Excitotoxicity: A Longitudinal Comparison with Microglial Activation, Astrogliosis, and Neuronal Death

D. Guilloteau, C. Tronel, N. Arlicot, 2014, Molecular imaging.

Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter.

J. Vercouillie, D. Guilloteau, A. Chartier, 2022, European journal of medicinal chemistry.

Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE

Denis Guilloteau, Myriam Bernaudin, Edwige Petit, 2010, European Journal of Nuclear Medicine and Molecular Imaging.